A Phase I Study of Clofarabine and Cytosine Arabinoside Therapy for Older Adults With Acute Myeloid Leukemia.

Trial Profile

A Phase I Study of Clofarabine and Cytosine Arabinoside Therapy for Older Adults With Acute Myeloid Leukemia.

Completed
Phase of Trial: Phase I

Latest Information Update: 24 Aug 2013

At a glance

  • Drugs Clofarabine; Cytarabine
  • Indications Acute myeloid leukaemia
  • Focus Therapeutic Use
  • Most Recent Events

    • 19 Apr 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 02 Mar 2011 Planned end date changed from 1 Mar 2011 to 1 Aug 2011 as reported by ClinicalTrials.gov.
    • 05 Jan 2010 Planned end date changed from 1 Mar 2010 to 1 Mar 2011 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top